| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 261 |
| 1 | METHOTREXATE | 227 |
| 2 | RITUXIMAB | 188 |
| 3 | PREDNISONE | 180 |
| 4 | MYCOPHENOLATE MOFETIL | 167 |
| 5 | ADALIMUMAB | 164 |
| 6 | AZATHIOPRINE | 161 |
| 7 | ABATACEPT | 150 |
| 8 | SULFASALAZINE | 150 |
| 9 | TOCILIZUMAB | 142 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVOMILNACIPRAN HYDROCHLORIDE | 84 | 0.0435 |
| 1 | PENICILLAMINE | 15 | 0.0162 |
| 2 | TRETINOIN | 92 | 0.0112 |
| 3 | MINOCYCLINE HYDROCHLORIDE | 64 | 0.0108 |
| 4 | TRIPROLIDINE HYDROCHLORIDE | 2 | 0.0103 |
| 5 | 12%AZELAIC ACID | 8 | 0.0095 |
| 6 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 8 | 0.0088 |
| 7 | BOTULINUM TOXIN TYPE A | 112 | 0.0088 |
| 8 | TRICLOSAN | 5 | 0.0087 |
| 9 | ICOSAPENT ETHYL | 75 | 0.0086 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 237 |
| 1 | Corticosteroid [EPC] | 225 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 207 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 190 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 190 |
| 5 | Purine Antimetabolite [EPC] | 161 |
| 6 | Aminosalicylate [EPC] | 159 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 150 |
| 8 | Anti-epileptic Agent [EPC] | 146 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 146 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 123 | 0.1788 |
| 1 | Provitamin D2 Compound [EPC] | 133 | 0.0045 |
| 2 | Interleukin-17A Antagonist [EPC] | 117 | 0.0031 |
| 3 | beta3-Adrenergic Agonist [EPC] | 103 | 0.0022 |
| 4 | Human C1 Esterase Inhibitor [EPC] | 7 | 0.0018 |
| 5 | Tetracycline-class Drug [EPC] | 126 | 0.0018 |
| 6 | Purine Antimetabolite [EPC] | 161 | 0.0016 |
| 7 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 8 | Aminosalicylate [EPC] | 159 | 0.0016 |
| 9 | Antirheumatic Agent [EPC] | 144 | 0.0014 |